| Literature DB >> 28725150 |
M Kaleemullah1, K Jiyauddin1, E Thiban1, S Rasha1, S Al-Dhalli1, S Budiasih1, O E Gamal2, A Fadli1, Y Eddy1.
Abstract
Currently, the use of natural gums and mucilage is of increasing importance in pharmaceutical formulations as valuable drug excipient. Natural plant-based materials are economic, free of side effects, biocompatible and biodegradable. Therefore, Ketoprofen matrix tablets were formulated by employing Hibiscus rosa-sinensis leaves mucilage as natural polymer and HPMC (K100M) as a synthetic polymer to sustain the drug release from matrix system. Direct compression method was used to develop sustained released matrix tablets. The formulated matrix tablets were evaluated in terms of physical appearance, weight variation, thickness, diameter, hardness, friability and in vitro drug release. The difference between the natural and synthetic polymers was investigated concurrently. Matrix tablets developed from each formulation passed all standard physical evaluation tests. The dissolution studies of formulated tablets revealed sustained drug release up to 24 h compared to the reference drug Apo Keto® SR tablets. The dissolution data later were fitted into kinetic models such as zero order equation, first order equation, Higuchi equation, Hixson Crowell equation and Korsmeyer-Peppas equation to study the release of drugs from each formulation. The best formulations were selected based on the similarity factor (f2) value of 50% and more. Through the research, it is found that by increasing the polymers concentration, the rate of drug release decreased for both natural and synthetic polymers. The best formulation was found to be F3 which contained 40% Hibiscus rosa-sinensis mucilage polymer and showed comparable dissolution profile to the reference drug with f2 value of 78.03%. The release kinetics of this formulation has shown to follow non-Fickian type which involved both diffusion and erosion mechanism. Additionally, the statistical results indicated that there was no significant difference (p > 0.05) between the F3 and reference drug in terms of MDT and T50% with p-values of 1.00 and 0.995 respectively.Entities:
Keywords: HPMC; Hibiscus rosa-sinensis; Ketoprofen; Mucilage; Sustained release
Year: 2016 PMID: 28725150 PMCID: PMC5506641 DOI: 10.1016/j.jsps.2016.10.006
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Figure 1Structure of Ketoprofen.
Figure 2Preparation of Ketoprofen sustained release tablet.
Formulation of Ketoprofen sustained release matrix tablets.
| Component | F1 (mg) | F2 (mg) | F3 (mg) | F4 (mg) | F5 (mg) | F6 (mg) | F7 (mg) |
|---|---|---|---|---|---|---|---|
| Ketoprofen | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
| 80 | 120 | 160 | – | – | – | 80 | |
| HPMC K100M | – | – | – | 80 | 120 | 160 | 80 |
| Lactose | 54 | 34 | 14 | 54 | 34 | 14 | 14 |
| Avicel PH102 | 54 | 34 | 14 | 54 | 34 | 14 | 14 |
| Talc | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Magnesium stearate | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Total weight of each tablet | 400 | 400 | 400 | 400 | 400 | 400 | 400 |
Taxonomical classification of Hibiscus rosa-sinensis.
| Kingdom | Plantae |
| Class | Magnoliopsida |
| Order | Malvales |
| Family | Malvaceae |
| Genus | Hibiscus |
| Species | Rosa-sinensis |
Physical characterization of Hibiscus rosa-sinensis leaves mucilage.
| Physical properties | Observation |
|---|---|
| Appearance | Brownish powder |
| Odour | Characteristic |
| Solubility | Progressive soluble in water forming viscous solution |
| Percentage yield (g/kg) | 21.58 g/kg |
| % Of moisture content | 14.70 ± 0.77 |
| % Of weight loss on drying | 12.82 ± 0.58 |
Mucilage flow properties.
| Flow properties | Observation |
|---|---|
| Angle of repose ( | 25.37 ± 0.434 |
| Bulk density (g/cm3) | 0.75 ± 0.014 |
| Tapped density (g/cm3) | 0.83 ± 0.017 |
| Carr’s index (%) | 9.44 ± 0.178 |
| Hausner’s ratio | 1.10 ± 0.002 |
Figure 3Ketoprofen standard curve.
Physical parameters evaluation of Ketoprofen formulations.
| Formulation | Physical parameters | ||||
|---|---|---|---|---|---|
| Average weight (mg) | Diameter (mm) | Thickness (mm) | Hardness (N) | Friability (%) | |
| F1 | 394.36 ± 2.34 | 10.12 ± 0.02 | 4.88 ± 0.03 | 49.2 ± 1.44 | 0.79 |
| F2 | 396.02 ± 3.69 | 10.11 ± 0.02 | 4.84 ± 0.07 | 45.8 ± 1.63 | 0.70 |
| F3 | 394.96 ± 4.87 | 10.11 ± 0.02 | 4.72 ± 0.10 | 57.7 ± 2.08 | 0.54 |
| F4 | 388.63 ± 1.96 | 10.11 ± 0.02 | 4.77 ± 0.06 | 62.0 ± 1.68 | 0.23 |
| F5 | 390.56 ± 4.32 | 10.10 ± 0.02 | 4.74 ± 0.02 | 55.5 ± 1.56 | 0.21 |
| F6 | 391.82 ± 2.60 | 10.11 ± 0.02 | 4.82 ± 0.04 | 54.9 ± 2.37 | 0.17 |
| F7 | 393.16 ± 3.53 | 10.10 ± 0.02 | 4.85 ± 0.03 | 60.8 ± 3.91 | 0.48 |
Figure 4Swelling behaviour of Ketoprofen formulations.
Figure 5Drug release analysis for all Ketoprofen formulations.
Figure 6Comparison between selective formulations with reference drug.
Release kinetics for all ketoprofen formulations.
| Formulation code | Release kinetics | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Zero order | First order | Higuchi | Korsmeyer Peppas | Hixson-Crowell | ||||||
| Reference | 0.959 | 3.955 | 0.973 | −0.112 | 0.986 | 20.714 | 0.998 | 0.703 | 0.998 | −0.116 |
| F1 | 0.677 | 3.806 | 0.918 | −0.321 | 0.888 | 22.523 | 0.945 | 0.446 | 0.842 | −0.191 |
| F2 | 0.839 | 4.025 | 0.973 | −0.245 | 0.972 | 22.387 | 0.985 | 0.513 | 0.982 | −0.172 |
| F3 | 0.958 | 3.716 | 0.990 | −0.090 | 0.988 | 19.503 | 0.998 | 0.693 | 0.999 | −0.100 |
| F4 | 0.919 | 4.055 | 0.926 | −0.216 | 0.991 | 21.761 | 0.997 | 0.532 | 0.988 | −0.161 |
| F5 | 0.959 | 4.122 | 0.948 | −0.145 | 0.982 | 21.552 | 0.993 | 0.650 | 0.994 | −0.135 |
| F6 | 0.894 | 2.333 | 0.951 | −0.036 | 0.990 | 12.680 | 0.990 | 0.599 | 0.934 | −0.048 |
| F7 | 0.947 | 4.281 | 0.946 | −0.161 | 0.979 | 22.497 | 0.994 | 0.750 | 0.997 | −0.144 |
Summary of similarity factor of Ketoprofen formulations.
| Formulation code | Similarity factor, |
|---|---|
| Reference | – |
| F1 | 28.01 |
| F2 | 39.48 |
| F3 | 78.03 |
| F4 | 51.39 |
| F5 | 77.52 |
| F6 | 38.89 |
| F7 | 69.78 |
MDT and T50% values for all formulations.
| Formulation code | T50% | Significant difference with reference drug | MDT | Significant difference with reference drug |
|---|---|---|---|---|
| Reference | 8.39 ± 0.10 | – | 9.03 ± 0.44 | – |
| F1 | 2.96 ± 0.65 | 3.34 ± 0.64 | ||
| F2 | 4.31 ± 0.16 | 5.55 ± 0.15 | ||
| F3 | 8.88 ± 0.13 | 8.90 ± 0.09 | ||
| F4 | 6.24 ± 0.88 | 7.19 ± 0.41 | ||
| F5 | 8.04 ± 0.23 | 8.61 ± 0.32 | ||
| F6 | 16.00 ± 2.07 | 7.25 ± 0.87 | ||
| F7 | 7.51 ± 0.08 | 8.37 ± 0.14 | ||